Posts by admin
Nathan’s Story: VCP Disease and the need for a Rare Disease Advisory Council in Georgia
Since I was a freshman at Georgia Tech, I have had a clock ticking in my head. Since my mother presented symptoms of the VCP gene mutation, I had grown up knowing that a rare disease existed in my family and that there was a 50% chance that I might get it as an adult…
Read MorePublic health professor awarded $600,000 NIH grant to study high-performing research organizations
Many scientific discoveries have transformed our lives and public health, and academia plays a significant role in the discovery process. Universities, and research institutions in particular, are eager to increase the flow of discoveries from life sciences research — but the how is less clear. To better understand the driving factors of quality research and…
Read MoreResearch in plant genomics is answering big biological questions
Buell’s research is contributing to breakthroughs in medicine, farming and energy production Since Robin Buell joined the University of Georgia faculty in fall 2021, there’s been a flurry of activity in her lab. Buell and her researchers have nine projects underway in plant genomics – and Buell has already secured millions of dollars in federal funding. This complex, very…
Read MoreGeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer, announced today that its Chairman & CEO, David Dodd, has been selected as a 2022 Georgia Titan 100. The Titan 100 program recognizes Georgia’s Top 100 CEOs & C-level executives. They represent the state’s most accomplished business leaders…
Read MoreThe Center for Global Health Innovation Announces Award of $9.8 Million Grant to Address Vaccine Hesitancy in 7 States
The Center for Global Health Innovation (CGHI) today announced the award of $9,850,664 from the Health Resources and Services Administration (HRSA) as part of the American Rescue Plan Act (ARPA) to fund the Center’s Vaccine Access and Training (VAT) initiative. “Public-private partnerships are essential to address public health crises at the community level. Our unique…
Read MoreEmory Alum to Lead Major Biotech Research Institute in Alabama
Dr. Neil Lamb to serve as President, Dr. Rick Myers to serve as Chief Scientific Officer HudsonAlpha Institute for Biotechnology announced today that NeilLamb, PhD, current Vice President for Educational Outreach, will be the new President of theInstitute effective July 1, 2022, as rapid economic growth and advancements in genomics andlife science research have driven…
Read MoreNew Report Shows Growth in Federal and Private Sector Medical R&D Investment: COVID-19 Spending Inflates Bottom Line
According to the U.S. Investments in Medical and Health Research and Development 2016-2020 report, released today by Research!America, total U.S. Investment in medical and health research and development (R&D) grew by 11.1% from 2019 to 2020, reaching $245.1 billion. The private sector continues to be our nation’s largest investor in medical and health R&D, accounting for 66%…
Read MoreTempus picks up CRO Highline Sciences as the precision medicine company expands its healthcare ambitions
Tempus, a precision medicine solutions company led by Groupon co-founder Eric Lefkofsky, has snagged Highline Sciences to expand its capabilities into complex clinical research. San Francisco-based Highline is a specialized, full-service clinical contract research organization (CRO) focused on oncology. The company manages and executes on early and late-stage clinical trials, applying a customized approach to each…
Read MoreTakeda’s Sequeira to head up newly created global portfolio division, Kim to lead US unit
Several years ago, Takeda CEO Christophe Weber lamented the lack of gender diversity in the drugmaker’s executive ranks. With a group of appointments Thursday, it appears the company has made strides on that front. Takeda unveiled four executive appointments on Thursday, two affecting women leaders in key positions. Ramona Sequeira, currently Takeda’s U.S. president and head of…
Read MorePfizer’s $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies
Pfizer is taking its Valneva-partnered Lyme disease vaccine into phase 3. With midphase data supporting a three-dose series, the allies plan to kick off a phase 3 clinical trial of the regimen in the third quarter. Valneva sold Pfizer the rights to multivalent protein subunit vaccine VLA15 for $130 million upfront in 2020. At that time, Valneva…
Read More